Bakers in for another 166k shares per filings yesterday. Decent base action at the moment and recent fav results from Brilacidin http://www.nasdaq.com/press-release/cellceutix-reports-very-encouraging-interim-analysis-of-phase-2-drug-candidate-brilacidin-for-20170327-00742